MacroGenics reports four responses among 16 evaluable clear cell cancer patients, with lower-dose lorigerlimab results ...
Single agent lorigerlimab demonstrated encouraging preliminary clinical activity in clear cell gynecologic cancer (CCGC) with a confirmed ORR of ...
ZW191 demonstrates compelling anti-tumor activity in heavily pretreated patients with platinum-resistant ovarian cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results